Position in DNA
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$183,900
-$65,400 QoQ
Shares Held
30,000
0.0% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Welch & Forbes LLC holds $98,675,155 across 6 Biotechnology names. DNA ranks #3 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
219,669 | $98,090,995 | |
| 2 | SRRK |
Scholar Rock Holding Corp
|
5,000 | $245,800 | |
| 3 | DNA |
Ginkgo Bioworks Holdings, Inc.
This page
|
30,000 | $183,900 | |
| 4 | CMPX |
Compass Therapeutics, Inc.
|
19,000 | $100,510 | |
| 5 | MIST |
Milestone Pharmaceuticals Inc.
|
25,000 | $29,750 | |
| 6 | DRMA |
Dermata Therapeutics, Inc.
|
20,000 | $24,200 |
All Filings in DNA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $183,900 | 30,000 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $249,300 | 30,000 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $437,400 | 30,000 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $337,500 | 30,000 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $171,000 | 30,000 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $294,600 | 30,000 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $462,512 | 56,750 | Shares | Sole | 2024-11-04 | |
| No filing history on record for this holder in this stock. | ||||||